Role of steroid therapy in Pseudoxanthoma elasticum-like papillary dermal elastolysis

12Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Pseudoxanthoma Elasticum-like Papillary Dermal Elastolysis (PXE-PDE) is a peculiar idiopathic elastolytic disorder that clinically resembles Psudoxanthoma elasticum (PXE). It is histologically characterized by a total or partial loss of elastic fibers in the papillary dermis. It more often affects elderly women and is characterized by asymptomatic and symmetrical yellowish papules localized predominantly on the neck, supraclavicular regions, and flexural areas. After analyzing a series of cases and the recent literature suggesting that glucocorticoids may down-regulate the elastin gene expression and elastin mRNA, in cultured human skin fibroblasts, we think that high dose and prolonged steroid therapy may contribute to the appearance of PXE-PDE lesions. Copyright © by BIOLIFE, s.a.s.

Cite

CITATION STYLE

APA

Pranteda, G., Muscianese, M., Marmo, G., Fidanza, L., Pranteda, G., Tamburi, F., … Nisticò, S. (2013). Role of steroid therapy in Pseudoxanthoma elasticum-like papillary dermal elastolysis. International Journal of Immunopathology and Pharmacology, 26(4), 1013–1018. https://doi.org/10.1177/039463201302600423

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free